Homo sapiens Protein: FIG4
Summary
InnateDB Protein IDBP-95180.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol FIG4
Protein Name FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae)
Synonyms ALS11; BTOP; CMT4J; dJ249I4.1; KIAA0274; SAC3; YVS;
Species Homo sapiens
Ensembl Protein ENSP00000230124
InnateDB Gene IDBG-95178 (FIG4)
Protein Structure
UniProt Annotation
Function The PI(3,5)P2 regulatory complex regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). In vitro, hydrolyzes all three D5-phosphorylated polyphosphoinositide substrates in the order PtdIns(4,5)P2 > PtdIns(3,5)P2 > PtdIns(3,4,5)P3. Plays a role in the biogenesis of endosome carrier vesicles (ECV) / multivesicular bodies (MVB) transport intermediates from early endosomes. {ECO:0000269PubMed:17556371}.
Subcellular Localization Endosome membrane {ECO:0000269PubMed:17556371}. Note=Localization requires VAC14 and PIKFYVE.
Disease Associations Charcot-Marie-Tooth disease 4J (CMT4J) [MIM:611228]: A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot- Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. {ECO:0000269PubMed:17572665}. Note=The disease is caused by mutations affecting the gene represented in this entry.Amyotrophic lateral sclerosis 11 (ALS11) [MIM:612577]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5- 10% of the cases. {ECO:0000269PubMed:19118816}. Note=The disease is caused by mutations affecting the gene represented in this entry.Yunis-Varon syndrome (YVS) [MIM:216340]: A severe autosomal recessive disorder characterized by skeletal defects, including cleidocranial dysplasia and digital anomalies, and severe neurologic involvement with neuronal loss. Enlarged cytoplasmic vacuoles are found in neurons, muscle, and cartilage. The disorder is usually lethal in infancy. {ECO:0000269PubMed:23623387}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 5 experimentally validated interaction(s) in this database.
Experimentally validated
Total 5 [view]
Protein-Protein 3 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 1 [view]
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0004438 phosphatidylinositol-3-phosphatase activity
GO:0005515 protein binding
GO:0034593 phosphatidylinositol bisphosphate phosphatase activity
GO:0042578 phosphoric ester hydrolase activity
GO:0043812 phosphatidylinositol-4-phosphate phosphatase activity
GO:0043813 phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity
Biological Process
GO:0006644 phospholipid metabolic process
GO:0006661 phosphatidylinositol biosynthetic process
GO:0007033 vacuole organization
GO:0007626 locomotory behavior
GO:0008219 cell death
GO:0010976 positive regulation of neuron projection development
GO:0016311 dephosphorylation
GO:0031642 negative regulation of myelination
GO:0032288 myelin assembly
GO:0036092 phosphatidylinositol-3-phosphate biosynthetic process
GO:0043473 pigmentation
GO:0044281 small molecule metabolic process
GO:0046488 phosphatidylinositol metabolic process
GO:0048666 neuron development
Cellular Component
GO:0000139 Golgi membrane
GO:0005783 endoplasmic reticulum
GO:0005794 Golgi apparatus
GO:0010008 endosome membrane
GO:0031901 early endosome membrane
GO:0031902 late endosome membrane
GO:0055037 recycling endosome
Protein Structure and Domains
PDB ID
InterPro IPR002013 Synaptojanin, N-terminal
PFAM PF02383
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q92562
PhosphoSite PhosphoSite-Q92562
TrEMBL Q5TCS4
UniProt Splice Variant
Entrez Gene 9896
UniGene Hs.529959
RefSeq NP_055660
HUGO HGNC:16873
OMIM 609390
CCDS CCDS5078
HPRD 11073
IMGT
EMBL AK222732 AL133472 AL512303 BC041338 D87464
GenPept AAH41338 BAA13403 BAD96452 CAI19669 CAI42494